Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_ModerateBP6_ModerateBS2
The NM_006044.4(HDAC6):āc.92C>Gā(p.Ser31Trp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000141 in 1,204,965 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/24 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ).
HDAC6 (HGNC:14064): (histone deacetylase 6) Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It contains an internal duplication of two catalytic domains which appear to function independently of each other. This protein possesses histone deacetylase activity and represses transcription. [provided by RefSeq, Jul 2008]
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), HDAC6. . Gene score misZ 3.2915 (greater than the threshold 3.09). GenCC has associacion of gene with X-linked dominant chondrodysplasia, Chassaing-Lacombe type.
BP4
Computational evidence support a benign effect (MetaRNN=0.09366143).
BP6
Variant X-48802784-C-G is Benign according to our data. Variant chrX-48802784-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 2660468.Status of the report is criteria_provided_single_submitter, 1 stars.
Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);Loss of phosphorylation at S31 (P = 0.023);